ISO Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
IsoPlexis Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ISO Community Narratives
There are no narratives available yet.
Recent ISO News & Updates
IsoPlexis Corporation Key Details
Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -2.67
- Gross Margin
- -5.52%
- Net Profit Margin
- -632.40%
- Debt/Equity Ratio
- 112.3%
IsoPlexis Corporation Competitors
Snowflake Analysis
About ISO
- Founded
- 2013
- Employees
- 290
- CEO
- WebsiteView website
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 0.8%
- 3 Months: 8.3%
- 1 Year: 17.8%
- Year to Date: 15.4%
The Utilities sector gained 3.1% while the market remained flat over the last week. As for the longer term, the market has risen 18% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›